{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:17:23Z","timestamp":1793315843471,"version":"4.5.0"},"reference-count":178,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,8,13]],"date-time":"2018-08-13T00:00:00Z","timestamp":1534118400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s00467-018-4005-4","type":"journal-article","created":{"date-parts":[[2018,8,13]],"date-time":"2018-08-13T06:19:15Z","timestamp":1534141155000},"page":"975-991","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":755,"title":["Oxidative stress in chronic kidney disease"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7813-551X","authenticated-orcid":false,"given":"Kristien","family":"Daenen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmin","family":"Andries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djalila","family":"Mekahli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Van Schepdael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Jouret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bert","family":"Bammens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,13]]},"reference":[{"key":"4005_CR1","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1093\/ndt\/gfg074","volume":"18","author":"F Locatelli","year":"2003","unstructured":"Locatelli F, Canaud B, Eckardt K-U, Stenvinkel P, Wanner C, Zoccali C (2003) Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. Nephrol Dial Transplant 18:1272\u20131280","journal-title":"Nephrol Dial Transplant"},{"key":"4005_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/WOX.0b013e3182439613","volume":"5","author":"E Birben","year":"2012","unstructured":"Birben E, Sahiner UM, Sackesen C, Erzurum S, Kalayci O (2012) Oxidative stress and antioxidant defense. World Allergy Organ J 5:9\u201319","journal-title":"World Allergy Organ J"},{"key":"4005_CR3","first-page":"1","volume":"2016","author":"S Meo Di","year":"2016","unstructured":"Di Meo S, Reed TT, Venditti P, Victor VM (2016) Role of ROS and RNS sources in physiological and pathological conditions. Oxidative Med Cell Longev 2016:1\u201344","journal-title":"Oxidative Med Cell Longev"},{"key":"4005_CR4","doi-asserted-by":"publisher","first-page":"F367","DOI":"10.1152\/ajprenal.00571.2013","volume":"306","author":"R Che","year":"2014","unstructured":"Che R, Yuan Y, Huang S, Zhang A (2014) Mitochondrial dysfunction in the pathophysiology of renal diseases. AJP Ren Physiol 306:F367\u2013F378","journal-title":"AJP Ren Physiol"},{"key":"4005_CR5","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.redox.2015.01.001","volume":"4","author":"A Sureshbabu","year":"2015","unstructured":"Sureshbabu A, Ryter SW, Choi ME (2015) Oxidative stress and autophagy: crucial modulators of kidney injury. Redox Biol 4:208\u2013214","journal-title":"Redox Biol"},{"key":"4005_CR6","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.ccl.2005.03.005","volume":"23","author":"J Himmelfarb","year":"2005","unstructured":"Himmelfarb J (2005) Relevance of oxidative pathways in the pathophysiology of chronic kidney disease. Cardiol Clin 23:319\u2013330","journal-title":"Cardiol Clin"},{"key":"4005_CR7","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3109\/10715762.2013.779373","volume":"47","author":"A Popolo","year":"2013","unstructured":"Popolo A, Autore G, Pinto A, Marzocco S (2013) Oxidative stress in patients with cardiovascular disease and chronic renal failure. Free Radic Res 47:346\u2013356","journal-title":"Free Radic Res"},{"key":"4005_CR8","doi-asserted-by":"publisher","first-page":"82","DOI":"10.2174\/157340310791162659","volume":"6","author":"L Sibal","year":"2010","unstructured":"Sibal L, Agarwal SC, Home PD, Boger RH (2010) The role of asymmetric dimethylarginine (ADMA) in endothelial dysfunction and cardiovascular disease. Curr Cardiol Rev 6:82\u201390","journal-title":"Curr Cardiol Rev"},{"key":"4005_CR9","doi-asserted-by":"crossref","unstructured":"Yu M, Kim YJ, Kang DH (2010) Indoxyl sulfate-induced endothelial dysfunction in patients with chronic kidney disease via an induction of oxidative stress 15. Clin J Am Soc Nephrol","DOI":"10.2215\/CJN.05340610"},{"key":"4005_CR10","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1681\/ASN.V591697","volume":"5","author":"RA Ward","year":"1995","unstructured":"Ward RA, McLeish KR (1995) Polymorphonuclear leukocyte oxidative burst is enhanced in patients with chronic renal insufficiency. J Am Soc Nephrol 5:1697\u20131702","journal-title":"J Am Soc Nephrol"},{"key":"4005_CR11","doi-asserted-by":"publisher","first-page":"358985","DOI":"10.1155\/2013\/358985","volume":"2013","author":"HF Tbahriti","year":"2013","unstructured":"Tbahriti HF, Kaddous A, Bouchenak M, Mekki K (2013) Effect of different stages of chronic kidney disease and renal replacement therapies on oxidant-antioxidant balance in uremic patients. Biochem Res Int 2013:358985","journal-title":"Biochem Res Int"},{"key":"4005_CR12","doi-asserted-by":"crossref","unstructured":"Jankowska M, Rutkowski B, D\u0119bska-\u015alizie\u0144 A (2017) Vitamins and microelement bioavailability in different stages of chronic kidney disease. Nutrients 9","DOI":"10.3390\/nu9030282"},{"key":"4005_CR13","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1152\/physrev.00047.2003","volume":"84","author":"R Stocker","year":"2004","unstructured":"Stocker R, Keaney JF Jr (2004) Role of oxidative modifications in atherosclerosis. Physiol Rev 84:1381\u20131478","journal-title":"Physiol Rev"},{"key":"4005_CR14","doi-asserted-by":"publisher","first-page":"393","DOI":"10.13075\/mp.5893.00137","volume":"66","author":"M Czerska","year":"2015","unstructured":"Czerska M, Miko\u0142ajewska K, Zieli\u0144ski M, Gromadzi\u0144ska J, W\u0105sowicz W (2015) Today\u2019s oxidative stress markers. Med Pr 66:393\u2013405","journal-title":"Med Pr"},{"key":"4005_CR15","first-page":"9","volume":"5","author":"E Birben","year":"2012","unstructured":"Birben E, Murat U, Md S, Sackesen C, Erzurum S, Kalayci O (2012) Oxidative stress and antioxidant defense. WAO J 5:9\u201319","journal-title":"WAO J"},{"key":"4005_CR16","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.yexmp.2006.09.008","volume":"83","author":"SR Pieczenik","year":"2007","unstructured":"Pieczenik SR, Neustadt J (2007) Mitochondrial dysfunction and molecular pathways of disease. Exp Mol Pathol 83:84\u201392","journal-title":"Exp Mol Pathol"},{"key":"4005_CR17","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.cardiores.2004.08.007","volume":"65","author":"RP Brandes","year":"2005","unstructured":"Brandes RP, Kreuzer J (2005) Vascular NADPH oxidases: molecular mechanisms of activation. Cardiovasc Res 65:16\u201327","journal-title":"Cardiovasc Res"},{"key":"4005_CR18","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.freeradbiomed.2007.03.027","volume":"43","author":"JD Lambeth","year":"2007","unstructured":"Lambeth JD (2007) Nox enzymes, ROS, and chronic disease: an example of antagonistic pleiotropy. Free Radic Biol Med 43:332\u2013347","journal-title":"Free Radic Biol Med"},{"key":"4005_CR19","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1111\/bph.13532","volume":"174","author":"G Teixeira","year":"2017","unstructured":"Teixeira G, Szyndralewiez C, Molango S, Carnesecchi S, Heitz F, Wiesel P, Wood JM (2017) Therapeutic potential of NADPH oxidase 1\/4 inhibitors. Br J Pharmacol 174:1647\u20131669","journal-title":"Br J Pharmacol"},{"key":"4005_CR20","first-page":"412","volume":"3","author":"F Chen","year":"2012","unstructured":"Chen F, Haigh S, Barman S, Fulton DJ (2012) From form to function: the role of Nox4 in the cardiovascular system. Front Physiol 3:412","journal-title":"Front Physiol"},{"key":"4005_CR21","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1161\/01.RES.0000163631.07205.fb","volume":"96","author":"H Cai","year":"2005","unstructured":"Cai H (2005) NAD(P)H oxidase-dependent self-propagation of hydrogen peroxide and vascular disease. Circ Res 96:818\u2013822","journal-title":"Circ Res"},{"key":"4005_CR22","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1476-5381.2010.01196.x","volume":"164","author":"U F\u00f6rstermann","year":"2011","unstructured":"F\u00f6rstermann U, Li H (2011) Therapeutic effect of enhancing endothelial nitric oxide synthase (eNOS) expression and preventing eNOS uncoupling. Br J Pharmacol 164:213\u2013223","journal-title":"Br J Pharmacol"},{"key":"4005_CR23","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1161\/01.ATV.0000110785.96039.f6","volume":"24","author":"NJ Alp","year":"2004","unstructured":"Alp NJ, Channon KM (2004) Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease. Arterioscler Thromb Vasc Biol 24:413\u2013420","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4005_CR24","doi-asserted-by":"publisher","first-page":"4255","DOI":"10.1074\/jbc.M116.739441","volume":"292","author":"G Yogalingam","year":"2017","unstructured":"Yogalingam G, Lee AR, Mackenzie DS, Maures TJ, Rafalko A, Prill H, Berguig GY, Hague C, Christianson T, Bell SM, LeBowitz JH (2017) Cellular uptake and delivery of myeloperoxidase to lysosomes promote lipofuscin degradation and lysosomal stress in retinal cells. J Biol Chem 292:4255\u20134265","journal-title":"J Biol Chem"},{"key":"4005_CR25","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.neubiorev.2016.06.031","volume":"68","author":"RS Ray","year":"2016","unstructured":"Ray RS, Katyal A (2016) Myeloperoxidase: bridging the gap in neurodegeneration. Neurosci Biobehav Rev 68:611\u2013620","journal-title":"Neurosci Biobehav Rev"},{"key":"4005_CR26","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1172\/JCI117342","volume":"94","author":"A Daugherty","year":"1994","unstructured":"Daugherty A, Dunn JL, Rateri DL, Heinecke JW (1994) Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest 94:437\u2013444","journal-title":"J Clin Invest"},{"key":"4005_CR27","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1056\/NEJMoa035003","volume":"349","author":"ML Brennan","year":"2003","unstructured":"Brennan ML, Penn MS, Van LF, Nambi V, Shishehbor MH, Aviles RJ, Goormastic M, Pepoy ML, McErlean ES, Topol EJ, Nissen SE, Hazen SL (2003) Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med 349:1595\u20131604","journal-title":"N Engl J Med"},{"key":"4005_CR28","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1373\/clinchem.2011.166827","volume":"57","author":"SJ Nicholls","year":"2011","unstructured":"Nicholls SJ, Tang WH, Brennan D, Brennan ML, Mann S, Nissen SE, Hazen SL (2011) Risk prediction with serial myeloperoxidase monitoring in patients with acute chest pain. Clin Chem 57:1762\u20131770","journal-title":"Clin Chem"},{"key":"4005_CR29","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s11357-997-0012-2","volume":"20","author":"HY Chung","year":"1997","unstructured":"Chung HY, Baek BS, Song SH, Kim MS, Huh JI, Shim KH, Kim KW, Lee KH (1997) Xanthine dehydrogenase\/xanthine oxidase and oxidative stress. Age (Omaha) 20:127\u2013140","journal-title":"Age (Omaha)"},{"key":"4005_CR30","doi-asserted-by":"crossref","first-page":"89","DOI":"10.59566\/IJBS.2008.4089","volume":"4","author":"LA Pham-Huy","year":"2008","unstructured":"Pham-Huy LA, He H, Pham-Huy C (2008) Free radicals, antioxidants in disease and health. Int J Biomed Sci 4:89\u201396","journal-title":"Int J Biomed Sci"},{"key":"4005_CR31","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1016\/S0891-5849(00)00231-8","volume":"28","author":"PL Fox","year":"2000","unstructured":"Fox PL, Mazumder B, Ehrenwald E, Mukhopadhyay CK (2000) Ceruloplasmin and cardiovascular disease. Free Radic Biol Med 28:1735\u20131744","journal-title":"Free Radic Biol Med"},{"key":"4005_CR32","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1172\/JCI118491","volume":"97","author":"E Ehrenwald","year":"1996","unstructured":"Ehrenwald E, Fox PL (1996) Role of endogenous ceruloplasmin in low density lipoprotein oxidation by human U937 monocytic cells. J Clin Invest 97:884\u2013890","journal-title":"J Clin Invest"},{"key":"4005_CR33","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1172\/JCI117127","volume":"93","author":"E Ehrenwald","year":"1994","unstructured":"Ehrenwald E, Chisolm GM, Fox PL (1994) Intact human ceruloplasmin oxidatively modifies low density lipoprotein. J Clin Invest 93:1493\u20131501","journal-title":"J Clin Invest"},{"key":"4005_CR34","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1165\/rcmb.2006-0340TR","volume":"36","author":"J Alam","year":"2007","unstructured":"Alam J, Cook JL (2007) How many transcription factors does it take to turn on the heme oxygenase-1 gene? Am J Respir Cell Mol Biol 36:166\u2013174","journal-title":"Am J Respir Cell Mol Biol"},{"key":"4005_CR35","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1146\/annurev.pharmtox.46.120604.141046","volume":"47","author":"TW Kensler","year":"2007","unstructured":"Kensler TW, Wakabayashi N, Biswal S (2007) Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol 47:89\u2013116","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"4005_CR36","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1089\/ars.2010.3586","volume":"15","author":"E Lubos","year":"2011","unstructured":"Lubos E, Loscalzo J, Handy DE (2011) Glutathione Peroxidase-1 in health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 15:1957\u20131997","journal-title":"Antioxid Redox Signal"},{"key":"4005_CR37","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1620\/tjem.200.167","volume":"200","author":"S Shibahara","year":"2003","unstructured":"Shibahara S (2003) The heme oxygenase dilemma in cellular homeostasis: new insights for the feedback regulation of heme catabolism. Tohoku J Exp Med 200:167\u2013186","journal-title":"Tohoku J Exp Med"},{"key":"4005_CR38","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.freeradbiomed.2016.06.016","volume":"97","author":"E Gonzalez-Sanchez","year":"2016","unstructured":"Gonzalez-Sanchez E, Perez MJ, Nytofte NS, Briz O, Monte MJ, Lozano E, Serrano MA, Marin JJG (2016) Protective role of biliverdin against bile acid-induced oxidative stress in liver cells. Free Radic Biol Med 97:466\u2013477","journal-title":"Free Radic Biol Med"},{"key":"4005_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2005.03.010","volume":"39","author":"NG Abraham","year":"2005","unstructured":"Abraham NG, Kappas A (2005) Heme oxygenase and the cardiovascular-renal system. Free Radic Biol Med 39:1\u201325","journal-title":"Free Radic Biol Med"},{"key":"4005_CR40","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1681\/ASN.2012040380","volume":"23","author":"KA Nath","year":"2012","unstructured":"Nath KA (2012) Human AKI and heme oxygenase-1. J Am Soc Nephrol 23:971\u2013974","journal-title":"J Am Soc Nephrol"},{"key":"4005_CR41","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.freeradbiomed.2004.11.019","volume":"38","author":"NOS Camara","year":"2005","unstructured":"Camara NOS, Soares MP (2005) Heme oxygenase-1 (HO-1), a protective gene that prevents chronic graft dysfunction. Free Radic Biol Med 38:426\u2013435","journal-title":"Free Radic Biol Med"},{"key":"4005_CR42","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1053\/jhep.2002.32467","volume":"35","author":"F Amersi","year":"2002","unstructured":"Amersi F, Shen X-D, Anselmo D, Melinek J, Iyer S, Southard DJ, Katori M, Volk H-D, Busuttil RW, Buelow R, Kupiec-Weglinski JW (2002) Ex vivo exposure to carbon monoxide prevents hepatic ischemia\/reperfusion injury through p38 MAP kinase pathway. Hepatology 35:815\u2013823","journal-title":"Hepatology"},{"key":"4005_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12013-009-9054-7","volume":"55","author":"EE Battin","year":"2009","unstructured":"Battin EE, Brumaghim JL (2009) Antioxidant activity of sulfur and selenium: a review of reactive oxygen species scavenging, glutathione peroxidase, and metal-binding antioxidant mechanisms. Cell Biochem Biophys 55:1\u201323","journal-title":"Cell Biochem Biophys"},{"key":"4005_CR44","first-page":"35","volume":"2","author":"AM Kabel","year":"2014","unstructured":"Kabel AM (2014) Free radicals and antioxidants: role of enzymes and nutrition. World J Nutr Heal 2:35\u201338","journal-title":"World J Nutr Heal"},{"key":"4005_CR45","first-page":"165","volume":"9","author":"A Modaresi","year":"2015","unstructured":"Modaresi A, Nafar M, Sahraei Z (2015) Oxidative stress in chronic kidney disease. Iran J Kidney Dis 9:165\u2013179","journal-title":"Iran J Kidney Dis"},{"key":"4005_CR46","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1080\/07315724.2003.10719272","volume":"22","author":"SJ Padayatty","year":"2003","unstructured":"Padayatty SJ, Katz A, Wang Y, Eck P, Kwon O, Lee J-H, Chen S, Corpe C, Dutta A, Dutta SK, Levine M (2003) Vitamin C as an antioxidant: evaluation of its role in disease prevention. J Am Coll Nutr 22:18\u201335","journal-title":"J Am Coll Nutr"},{"key":"4005_CR47","doi-asserted-by":"publisher","first-page":"270","DOI":"10.4161\/oxim.2.5.9498","volume":"2","author":"KB Pandey","year":"2009","unstructured":"Pandey KB, Rizvi SI (2009) Plant polyphenols as dietary antioxidants in human health and disease. Oxidative Med Cell Longev 2:270\u2013278","journal-title":"Oxidative Med Cell Longev"},{"key":"4005_CR48","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1017\/S0007114515002822","volume":"114","author":"R Sansone","year":"2015","unstructured":"Sansone R, Rodriguez-Mateos A, Heuel J, Falk D, Schuler D, Wagstaff R, Kuhnle GG, Spencer JP, Schroeter H, Merx MW, Kelm M, Heiss C (2015) Cocoa flavanol intake improves endothelial function and Framingham Risk Score in healthy men and women: a randomised, controlled, double-masked trial: the Flaviola Health Study. Br J Nutr 114:1246\u20131255","journal-title":"Br J Nutr"},{"key":"4005_CR49","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1016\/j.febslet.2008.04.057","volume":"582","author":"M Roche","year":"2008","unstructured":"Roche M, Rondeau P, Singh NR, Tarnus E, Bourdon E (2008) The antioxidant properties of serum albumin. FEBS Lett 582:1783\u20131787","journal-title":"FEBS Lett"},{"key":"4005_CR50","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.exger.2007.10.013","volume":"43","author":"AS Prasad","year":"2008","unstructured":"Prasad AS (2008) Clinical, immunological, anti-inflammatory and antioxidant roles of zinc. Exp Gerontol 43:370\u2013377","journal-title":"Exp Gerontol"},{"key":"4005_CR51","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1080\/07315724.2008.10719741","volume":"27","author":"H Shen","year":"2008","unstructured":"Shen H, Oesterling E, Stromberg A, Toborek M, MacDonald R, Hennig B (2008) Zinc deficiency induces vascular pro-inflammatory parameters associated with NF-kappaB and PPAR signaling. J Am Coll Nutr 27:577\u2013587","journal-title":"J Am Coll Nutr"},{"key":"4005_CR52","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/S0002-8223(99)00198-4","volume":"99","author":"DH Holben","year":"1999","unstructured":"Holben DH, Smith AM (1999) The diverse role of selenium within selenoproteins: a review. J Am Diet Assoc 99:836\u2013843","journal-title":"J Am Diet Assoc"},{"key":"4005_CR53","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1042\/cs0840611","volume":"84","author":"D Girelli","year":"1993","unstructured":"Girelli D, Olivieri O, Stanzial AM, Azzini M, Lupo A, Bernich P, Menini C, Gammaro L, Corrocher R (1993) Low platelet glutathione peroxidase activity and serum selenium concentration in patients with chronic renal failure: relations to dialysis treatments, diet and cardiovascular complications. Clin Sci (Lond) 84:611\u2013617","journal-title":"Clin Sci (Lond)"},{"key":"4005_CR54","doi-asserted-by":"publisher","first-page":"4256","DOI":"10.2174\/092986710793348581","volume":"17","author":"N Kashihara","year":"2010","unstructured":"Kashihara N, Haruna Y, Kondeti VK, Kanwar YS (2010) Oxidative stress in diabetic nephropathy. Curr Med Chem 17:4256\u20134269","journal-title":"Curr Med Chem"},{"key":"4005_CR55","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.2337\/db08-0057","volume":"57","author":"JM Forbes","year":"2008","unstructured":"Forbes JM, Coughlan MT, Cooper ME (2008) Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 57:1446\u20131454","journal-title":"Diabetes"},{"key":"4005_CR56","doi-asserted-by":"publisher","unstructured":"Galvan DL, Green NH, Danesh FR (2017) The hallmarks of mitochondrial dysfunction in chronic kidney disease. Kidney Int. https:\/\/doi.org\/10.1016\/j.kint.2017.05.034","DOI":"10.1016\/j.kint.2017.05.034"},{"key":"4005_CR57","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1186\/1471-2164-10-388","volume":"10","author":"S Granata","year":"2009","unstructured":"Granata S, Zaza G, Simone S, Villani G, Latorre D, Pontrelli P, Carella M, Schena FP, Grandaliano G, Pertosa G (2009) Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease. BMC Genomics 10:388","journal-title":"BMC Genomics"},{"key":"4005_CR58","doi-asserted-by":"publisher","unstructured":"Ishimoto Y, Inagi R, Yoshihara D, Kugita M, Nagao S, Shimizu A, Takeda N, Wake M, Honda K, Zhou J, Nangaku M (2017) Mitochondrial abnormality facilitates cyst formation in autosomal dominant polycystic kidney disease. Mol Cell Biol. https:\/\/doi.org\/10.1128\/MCB.00337-17","DOI":"10.1128\/MCB.00337-17"},{"key":"4005_CR59","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1042\/CS20150427","volume":"129","author":"AD McClelland","year":"2015","unstructured":"McClelland AD, Herman-Edelstein M, Komers R, Jha JC, Winbanks CE, Hagiwara S, Gregorevic P, Kantharidis P, Cooper ME (2015) miR-21 promotes renal fibrosis in diabetic nephropathy by targeting PTEN and SMAD7. Clin Sci (Lond) 129:1237\u20131249","journal-title":"Clin Sci (Lond)"},{"key":"4005_CR60","doi-asserted-by":"publisher","first-page":"c286","DOI":"10.1159\/000235946","volume":"113","author":"F Locatelli","year":"2009","unstructured":"Locatelli F, Del Vecchio L, Cavalli A (2009) Inhibition of the renin-angiotensin system in chronic kidney disease: a critical look to single and dual blockade. Nephron Clin Pract 113:c286\u2013c293","journal-title":"Nephron Clin Pract"},{"key":"4005_CR61","first-page":"29","volume":"8","author":"R Yacoub","year":"2015","unstructured":"Yacoub R, Campbell KN (2015) Inhibition of RAS in diabetic nephropathy. Int J Nephrol Renov Dis 8:29\u201340","journal-title":"Int J Nephrol Renov Dis"},{"key":"4005_CR62","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1111\/j.1538-7836.2007.02540.x","volume":"5","author":"L Dou","year":"2007","unstructured":"Dou L, Jourde-Chiche N, Faure V, Cerini C, Berland Y, gnat-George F, Brunet P (2007) The uremic solute indoxyl sulfate induces oxidative stress in endothelial cells. J Thromb Haemost 5:1302\u20131308","journal-title":"J Thromb Haemost"},{"key":"4005_CR63","doi-asserted-by":"publisher","first-page":"C47","DOI":"10.1152\/ajpcell.00208.2016","volume":"312","author":"MS Li","year":"2017","unstructured":"Li MS, Adesina SE, Ellis CL, Gooch JL, Hoover RS, Williams CR (2017) NADPH oxidase-2 mediates zinc deficiency-induced oxidative stress and kidney damage. Am J Phys Cell Phys 312:C47\u2013C55","journal-title":"Am J Phys Cell Phys"},{"key":"4005_CR64","doi-asserted-by":"publisher","first-page":"856085","DOI":"10.1155\/2012\/856085","volume":"2012","author":"X Kong","year":"2012","unstructured":"Kong X, Zhang Y, Wu H, Li F, Zhang D, Su Q (2012) Combination therapy with losartan and pioglitazone additively reduces renal oxidative and nitrative stress induced by chronic high fat, sucrose, and sodium intake. Oxidative Med Cell Longev 2012:856085","journal-title":"Oxidative Med Cell Longev"},{"key":"4005_CR65","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1161\/01.RES.66.3.722","volume":"66","author":"SK Wilson","year":"1990","unstructured":"Wilson SK (1990) Role of oxygen-derived free radicals in acute angiotensin II-induced hypertensive vascular disease in the rat. Circ Res 66:722\u2013734","journal-title":"Circ Res"},{"key":"4005_CR66","doi-asserted-by":"publisher","first-page":"30","DOI":"10.2215\/CJN.05340610","volume":"6","author":"M Yu","year":"2011","unstructured":"Yu M, Kim YJ, Kang D-H (2011) Indoxyl sulfate-induced endothelial dysfunction in patients with chronic kidney disease via an induction of oxidative stress. Clin J Am Soc Nephrol 6:30\u201339","journal-title":"Clin J Am Soc Nephrol"},{"key":"4005_CR67","doi-asserted-by":"publisher","first-page":"E685","DOI":"10.1152\/ajpendo.2001.280.5.E685","volume":"280","author":"MP Wautier","year":"2001","unstructured":"Wautier MP, Chappey O, Corda S, Stern DM, Schmidt AM, Wautier JL (2001) Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am J Physiol Endocrinol Metab 280:E685\u2013E694","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"4005_CR68","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1159\/000191468","volume":"29","author":"Z Tumur","year":"2009","unstructured":"Tumur Z, Niwa T (2009) Indoxyl sulfate inhibits nitric oxide production and cell viability by inducing oxidative stress in vascular endothelial cells. Am J Nephrol 29:551\u2013557","journal-title":"Am J Nephrol"},{"key":"4005_CR69","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.jacc.2005.04.040","volume":"46","author":"F Perticone","year":"2005","unstructured":"Perticone F, Sciacqua A, Maio R, Perticone M, Maas R, Boger RH, Tripepi G, Sesti G, Zoccali C (2005) Asymmetric dimethylarginine, L-arginine, and endothelial dysfunction in essential hypertension. J Am Coll Cardiol 46:518\u2013523","journal-title":"J Am Coll Cardiol"},{"key":"4005_CR70","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s10157-007-0471-x","volume":"11","author":"S Ueda","year":"2007","unstructured":"Ueda S, Yamagishi S, Matsumoto Y, Fukami K, Okuda S (2007) Asymmetric dimethylarginine (ADMA) is a novel emerging risk factor for cardiovascular disease and the development of renal injury in chronic kidney disease. Clin Exp Nephrol 11:115\u2013121","journal-title":"Clin Exp Nephrol"},{"key":"4005_CR71","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/eci.12564","volume":"46","author":"L Correia-Costa","year":"2016","unstructured":"Correia-Costa L, Sousa T, Morato M, Cosme D, Afonso J, Moura C, Mota C, Areias JC, Guerra A, Schaefer F, Caldas Afonso A, Barros H, Albino-Teixeira A, Azevedo A (2016) Association of myeloperoxidase levels with cardiometabolic factors and renal function in prepubertal children. Eur J Clin Investig 46:50\u201359","journal-title":"Eur J Clin Investig"},{"key":"4005_CR72","doi-asserted-by":"crossref","unstructured":"Pecoits-Filho R, Stenvinkel P, Marchlewska A, Heimburger O, Barany P, Hoff CM, Holmes CJ, Suliman M, Lindholm B, Schalling M, Nordfors L (2003) A functional variant of the myeloperoxidase gene is associated with cardiovascular disease in end-stage renal disease patients. Kidney Int Suppl:S172\u2013S176","DOI":"10.1046\/j.1523-1755.63.s84.32.x"},{"key":"4005_CR73","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000441091","volume":"131","author":"B Gondouin","year":"2015","unstructured":"Gondouin B, Jourde-Chiche N, Sallee M, Dou L, Cerini C, Loundou A, Morange S, Berland Y, Burtey S, Brunet P, Guieu R, Dussol B (2015) Plasma xanthine oxidase activity is predictive of cardiovascular disease in patients with chronic kidney disease, independently of uric acid levels. Nephron 131:167\u2013174","journal-title":"Nephron"},{"key":"4005_CR74","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/hr.2016.37","volume":"39","author":"K Kohagura","year":"2016","unstructured":"Kohagura K, Tana T, Higa A, Yamazato M, Ishida A, Nagahama K, Sakima A, Iseki K, Ohya Y (2016) Effects of xanthine oxidase inhibitors on renal function and blood pressure in hypertensive patients with hyperuricemia. Hypertens Res 39:593\u2013597","journal-title":"Hypertens Res"},{"key":"4005_CR75","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1681\/ASN.2013080838","volume":"25","author":"KL Kuo","year":"2014","unstructured":"Kuo KL, Hung SC, Lee TS, Tarng DC (2014) Iron sucrose accelerates early atherogenesis by increasing superoxide production and upregulating adhesion molecules in CKD. J Am Soc Nephrol 25:2596\u20132606","journal-title":"J Am Soc Nephrol"},{"key":"4005_CR76","doi-asserted-by":"publisher","first-page":"462","DOI":"10.2215\/CJN.07720713","volume":"9","author":"DJ Kennedy","year":"2014","unstructured":"Kennedy DJ, Fan Y, Wu Y, Pepoy M, Hazen SL, Tang WH (2014) Plasma ceruloplasmin, a regulator of nitric oxide activity, and incident cardiovascular risk in patients with CKD. Clin J Am Soc Nephrol 9:462\u2013467","journal-title":"Clin J Am Soc Nephrol"},{"key":"4005_CR77","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/0891-5849(96)00233-X","volume":"21","author":"I Ceballos-Picot","year":"1996","unstructured":"Ceballos-Picot I, Witko-Sarsat V, Merad-Boudia M, Nguyen AT, Thevenin M, Jaudon MC, Zingraff J, Verger C, Jungers P, Descamps-Latscha B (1996) Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure. Free Radic Biol Med 21:845\u2013853","journal-title":"Free Radic Biol Med"},{"key":"4005_CR78","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/bs.acc.2014.11.006","volume":"68","author":"BA Zachara","year":"2015","unstructured":"Zachara BA (2015) Selenium and selenium-dependent antioxidants in chronic kidney disease. Adv Clin Chem 68:131\u2013151","journal-title":"Adv Clin Chem"},{"key":"4005_CR79","first-page":"242","volume":"7","author":"G Bellisola","year":"1993","unstructured":"Bellisola G, Perona G, Galassini S, Moschini G, Guidi GC (1993) Plasma selenium and glutathione peroxidase activities in individuals living in the Veneto region of Italy. J Trace Elem Electrolytes Health Dis 7:242\u2013244","journal-title":"J Trace Elem Electrolytes Health Dis"},{"key":"4005_CR80","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1093\/ndt\/gfm736","volume":"23","author":"AE Courtney","year":"2007","unstructured":"Courtney AE, McNamee PT, Heggarty S, Middleton D, Maxwell AP (2007) Association of functional haem oxygenase-1 gene promoter polymorphism with polycystic kidney disease and IgA nephropathy. Nephrol Dial Transplant 23:608\u2013611","journal-title":"Nephrol Dial Transplant"},{"key":"4005_CR81","doi-asserted-by":"crossref","unstructured":"Chen YH, Hung SC, Tarng DC (2013) Length polymorphism in heme oxygenase-1 and cardiovascular events and mortality in hemodialysis patients. Clin J Am Soc Nephrol","DOI":"10.2215\/CJN.01110113"},{"key":"4005_CR82","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/S0272-6386(03)00653-X","volume":"42","author":"M Danielski","year":"2003","unstructured":"Danielski M, Ikizler TA, McMonagle E, Kane JC, Pupim L, Morrow J, Himmelfarb J (2003) Linkage of hypoalbuminemia, inflammation, and oxidative stress in patients receiving maintenance hemodialysis therapy. Am J Kidney Dis 42:286\u2013294","journal-title":"Am J Kidney Dis"},{"key":"4005_CR83","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1900\/RDS.2008.5.102","volume":"5","author":"M Parham","year":"2008","unstructured":"Parham M, Amini M, Aminorroaya A, Heidarian E (2008) Effect of zinc supplementation on microalbuminuria in patients with type 2 diabetes: a double blind, randomized, placebo-controlled, cross-over trial. Rev Diabet Stud 5:102\u2013109","journal-title":"Rev Diabet Stud"},{"key":"4005_CR84","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3109\/15376516.2012.735277","volume":"23","author":"B Li","year":"2013","unstructured":"Li B, Tan Y, Sun W, Fu Y, Miao L, Cai L (2013) The role of zinc in the prevention of diabetic cardiomyopathy and nephropathy. Toxicol Mech Methods 23:27\u201333","journal-title":"Toxicol Mech Methods"},{"key":"4005_CR85","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1046\/j.1523-1755.2001.00807.x","volume":"60","author":"J Himmelfarb","year":"2001","unstructured":"Himmelfarb J, McMonagle E (2001) Albumin is the major plasma protein target of oxidant stress in uremia. Kidney Int 60:358\u2013363","journal-title":"Kidney Int"},{"key":"4005_CR86","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.atherosclerosis.2014.04.004","volume":"235","author":"AW Ashor","year":"2014","unstructured":"Ashor AW, Lara J, Mathers JC, Siervo M (2014) Effect of vitamin C on endothelial function in health and disease: a systematic review and meta-analysis of randomised controlled trials. Atherosclerosis 235:9\u201320","journal-title":"Atherosclerosis"},{"key":"4005_CR87","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/S0140-6736(00)02783-5","volume":"356","author":"M Boaz","year":"2000","unstructured":"Boaz M, Smetana S, Weinstein T, Matas Z, Gafter U, Iaina A, Knecht A, Weissgarten Y, Brunner D, Fainaru M, Green MS (2000) Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet 356:1213\u20131218","journal-title":"Lancet"},{"key":"4005_CR88","doi-asserted-by":"publisher","first-page":"108","DOI":"10.2215\/CJN.05560515","volume":"11","author":"T Rassaf","year":"2016","unstructured":"Rassaf T, Rammos C, Hendgen-Cotta UB, Heiss C, Kleophas W, Dellanna F, Floege J, Hetzel GR, Kelm M (2016) Vasculoprotective effects of dietary cocoa flavanols in patients on hemodialysis: a double-blind, randomized, placebo-controlled trial. Clin J Am Soc Nephrol 11:108\u2013118","journal-title":"Clin J Am Soc Nephrol"},{"key":"4005_CR89","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1089\/ars.2008.2034","volume":"10","author":"R Nistala","year":"2008","unstructured":"Nistala R, Whaley-Connell A, Sowers JR (2008) Redox control of renal function and hypertension. Antioxid Redox Signal 10:2047\u20132089","journal-title":"Antioxid Redox Signal"},{"key":"4005_CR90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/7520231","volume":"2016","author":"D Drozdz","year":"2016","unstructured":"Drozdz D, Kwinta P, Sztefko K, Kordon Z, Drozdz T, \u0141\u0105tka M, Miklaszewska M, Zachwieja K, Rudzi\u0144ski A, Pietrzyk JA (2016) Oxidative stress biomarkers and left ventricular hypertrophy in children with chronic kidney disease. Oxidative Med Cell Longev 2016:1\u20138","journal-title":"Oxidative Med Cell Longev"},{"key":"4005_CR91","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00467-013-2626-1","volume":"29","author":"JA Garcia-Bello","year":"2014","unstructured":"Garcia-Bello JA, G\u00f3mez-D\u00edaz RA, Contreras-Rodr\u00edguez A, Talavera JO, Mondrag\u00f3n-Gonz\u00e1lez R, Sanchez-Barbosa L, Diaz-Flores M, Valladares-Salgado A, Gallardo JM, Aguilar-Kitsu A, Lagunas-Munoz J, Wacher NH (2014) Carotid intima media thickness, oxidative stress, and inflammation in children with chronic kidney disease. Pediatr Nephrol 29:273\u2013281","journal-title":"Pediatr Nephrol"},{"key":"4005_CR92","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s00467-012-2323-5","volume":"28","author":"J Kotur-Stevuljevi\u0107","year":"2013","unstructured":"Kotur-Stevuljevi\u0107 J, Peco-Anti\u0107 A, Spasi\u0107 S, Stefanovi\u0107 A, Paripovi\u0107 D, Kosti\u0107 M, Vasi\u0107 D, Vujovi\u0107 A, Jeli\u0107-Ivanovi\u0107 Z, Spasojevi\u0107-Kalimanovska V, Kornic-Ristovski D (2013) Hyperlipidemia, oxidative stress, and intima media thickness in children with chronic kidney disease. Pediatr Nephrol 28:295\u2013303","journal-title":"Pediatr Nephrol"},{"key":"4005_CR93","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1253\/circj.CJ-15-0412","volume":"79","author":"S-J Chien","year":"2015","unstructured":"Chien S-J, Lin I-C, Hsu C-N, Lo M-H, Tain Y-L (2015) Homocysteine and arginine-to-asymmetric dimethylarginine ratio associated with blood pressure abnormalities in children with early chronic kidney disease. Circ J 79:2031\u20132037","journal-title":"Circ J"},{"key":"4005_CR94","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1053\/j.jrn.2010.05.002","volume":"20","author":"T Niwa","year":"2010","unstructured":"Niwa T (2010) Indoxyl sulfate is a nephro-vascular toxin 28. J Ren Nutr 20:S2\u2013S6","journal-title":"J Ren Nutr"},{"key":"4005_CR95","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1053\/j.ajkd.2005.09.029","volume":"47","author":"MI Yilmaz","year":"2006","unstructured":"Yilmaz MI, Saglam M, Caglar K, Cakir E, Sonmez A, Ozgurtas T, Aydin A, Eyileten T, Ozcan O, Acikel C, Tasar M, Genctoy G, Erbil K, Vural A, Zoccali C (2006) The determinants of endothelial dysfunction in CKD: oxidative stress and asymmetric dimethylarginine. Am J Kidney Dis 47:42\u201350","journal-title":"Am J Kidney Dis"},{"key":"4005_CR96","doi-asserted-by":"publisher","first-page":"H2649","DOI":"10.1152\/ajpheart.00548.2005","volume":"289","author":"N Tyagi","year":"2005","unstructured":"Tyagi N, Sedoris KC, Steed M, Ovechkin AV, Moshal KS, Tyagi SC (2005) Mechanisms of homocysteine-induced oxidative stress. Am J Physiol Hear Circ Physiol 289:H2649\u2013H2656","journal-title":"Am J Physiol Hear Circ Physiol"},{"key":"4005_CR97","doi-asserted-by":"publisher","first-page":"18473","DOI":"10.1074\/jbc.M110.118182","volume":"285","author":"B Shao","year":"2010","unstructured":"Shao B, Pennathur S, Pagani I, Oda MN, Witztum JL, Oram JF, Heinecke JW (2010) Modifying apolipoprotein A-I by malondialdehyde, but not by an array of other reactive carbonyls, blocks cholesterol efflux by the ABCA1 pathway. J Biol Chem 285:18473\u201318484","journal-title":"J Biol Chem"},{"key":"4005_CR98","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1046\/j.1523-1755.1999.00613.x","volume":"56","author":"M Boaz","year":"1999","unstructured":"Boaz M, Matas Z, Biro A, Katzir Z, Green M, Fainaru M, Smetana S (1999) Serum malondialdehyde and prevalent cardiovascular disease in hemodialysis. Kidney Int 56:1078\u20131083","journal-title":"Kidney Int"},{"key":"4005_CR99","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/sj.ki.5002794","volume":"74","author":"P Gailly","year":"2008","unstructured":"Gailly P, Jouret F, Martin D, Debaix H, Parreira KS, Nishita T, Blanchard A, Antignac C, Willnow TE, Courtoy PJ, Scheinman SJ, Christensen EI, Devuyst O (2008) A novel renal carbonic anhydrase type III plays a role in proximal tubule dysfunction. Kidney Int 74:52\u201361","journal-title":"Kidney Int"},{"key":"4005_CR100","doi-asserted-by":"publisher","unstructured":"Andries A, Daenen KEL, Jouret F, Bammens B, Mekhali D, Van Schepdael A (2018) Oxidative stress in autosomal dominant polycystic kidney disease: player and \/ or early predictor for disease progression? https:\/\/doi.org\/10.1007\/s00467-018-4004-5","DOI":"10.1007\/s00467-018-4004-5"},{"key":"4005_CR101","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/j.lfs.2013.05.008","volume":"92","author":"M Yisireyili","year":"2013","unstructured":"Yisireyili M, Shimizu H, Saito S, Enomoto A, Nishijima F, Niwa T (2013) Indoxyl sulfate promotes cardiac fibrosis with enhanced oxidative stress in hypertensive rats. Life Sci 92:1180\u20131185","journal-title":"Life Sci"},{"key":"4005_CR102","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1159\/000299798","volume":"31","author":"Z Tumur","year":"2010","unstructured":"Tumur Z, Shimizu H, Enomoto A, Miyazaki H, Niwa T (2010) Indoxyl sulfate upregulates expression of ICAM-1 and MCP-1 by oxidative stress-induced NF-kappaB activation. Am J Nephrol 31:435\u2013441","journal-title":"Am J Nephrol"},{"key":"4005_CR103","doi-asserted-by":"publisher","first-page":"F141","DOI":"10.1152\/ajprenal.00293.2011","volume":"302","author":"JL Finch","year":"2011","unstructured":"Finch JL, Suarez EB, Husain K, Ferder L, Cardema MC, Glenn DJ, Gardner DG, Liapis H, Slatopolsky E (2011) The effect of combining an ACE inhibitor and a VDR activator on glomerulosclerosis, proteinuria and renal oxidative stress in uremic rats. Am J Physiol Ren Physiol 302:F141\u2013149","journal-title":"Am J Physiol Ren Physiol"},{"key":"4005_CR104","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/ki.2011.476","volume":"81","author":"H Kajimoto","year":"2012","unstructured":"Kajimoto H, Kai H, Aoki H, Yasuoka S, Anegawa T, Aoki Y, Ueda S, Okuda S, Imaizumi T (2012) Inhibition of eNOS phosphorylation mediates endothelial dysfunction in renal failure: new effect of asymmetric dimethylarginine. Kidney Int 81:762\u2013768","journal-title":"Kidney Int"},{"key":"4005_CR105","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1017\/S0007114516002804","volume":"116","author":"L Correia-Costa","year":"2016","unstructured":"Correia-Costa L, Sousa T, Morato M, Cosme D, Afonso J, Areias JC, Schaefer F, Guerra A, Afonso AC, Azevedo A, Albino-Teixeira A (2016) Oxidative stress and nitric oxide are increased in obese children and correlate with cardiometabolic risk and renal function. Br J Nutr 116:805\u2013815","journal-title":"Br J Nutr"},{"key":"4005_CR106","unstructured":"Marcovecchio ML, de Giorgis T, Di Giovanni I, Chiavaroli V, Chiarelli F, Mohn A (2016) Association between markers of endothelial dysfunction and early signs of renal dysfunction in pediatric obesity and type 1 diabetes. Pediatr Diabetes:1\u20137"},{"key":"4005_CR107","doi-asserted-by":"publisher","first-page":"F407","DOI":"10.1152\/ajprenal.00262.2014","volume":"307","author":"A Lehners","year":"2014","unstructured":"Lehners A, Lange S, Niemann G, Rosendahl A, Meyer-Schwesinger C, Oh J, Stahl R, Ehmke H, Benndorf R, Klinke A, Baldus S, Wenzel UO (2014) Myeloperoxidase deficiency ameliorates progression of chronic kidney disease in mice. Am J Physiol Ren Physiol 307:F407\u2013F417","journal-title":"Am J Physiol Ren Physiol"},{"key":"4005_CR108","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1089\/ars.2011.3999","volume":"15","author":"T Fukai","year":"2011","unstructured":"Fukai T, Ushio-Fukai M (2011) Superoxide dismutases: role in redox signaling, vascular function, and diseases. Antioxid Redox Signal 15:1583\u20131606","journal-title":"Antioxid Redox Signal"},{"key":"4005_CR109","doi-asserted-by":"crossref","unstructured":"Zachara BA, Koterska D, Manitius J, Sadowski L, Dziedziczko A, Salak A, Wasowicz W (2004) Selenium supplementation on plasma glutathione peroxidase activity in patients with end-stage chronic renal failure. Biol Trace Elem Res:15","DOI":"10.1385\/BTER:97:1:1"},{"key":"4005_CR110","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/j.1525-1594.1995.tb02357.x","volume":"19","author":"M Bonomini","year":"1995","unstructured":"Bonomini M, Albertazzi A (1995) Selenium in uremia. Artif Organs 19:443\u2013448","journal-title":"Artif Organs"},{"key":"4005_CR111","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.1093\/ndt\/gfq859","volume":"26","author":"Y Fujishima","year":"2011","unstructured":"Fujishima Y, Ohsawa M, Itai K, Kato K, Tanno K, Turin TC, Onoda T, Endo S, Okayama A, Fujioka T (2011) Serum selenium levels are inversely associated with death risk among hemodialysis patients. Nephrol Dial Transplant 26:3331\u20133338","journal-title":"Nephrol Dial Transplant"},{"key":"4005_CR112","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1681\/ASN.2013111205","volume":"25","author":"Y-H Chen","year":"2014","unstructured":"Chen Y-H, Kuo K-L, Hung S-C, Hsu C-C, Chen Y-H, Tarng D-C (2014) Length polymorphism in heme oxygenase-1 and risk of CKD among patients with coronary artery disease. J Am Soc Nephrol 25:2669\u20132677","journal-title":"J Am Soc Nephrol"},{"key":"4005_CR113","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.cjca.2015.06.006","volume":"32","author":"KEL Daenen","year":"2016","unstructured":"Daenen KEL, Martens P, Bammens B (2016) Association of HO-1 (GT)n promoter polymorphism and cardiovascular disease: a reanalysis of the literature. Can J Cardiol 32:160\u2013168","journal-title":"Can J Cardiol"},{"key":"4005_CR114","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1681\/ASN.2016010038","volume":"27","author":"DE Leaf","year":"2016","unstructured":"Leaf DE, Body SC, Muehlschlegel JD, McMahon GM, Lichtner P, Collard CD, Shernan SK, Fox AA, Waikar SS (2016) Length polymorphisms in heme oxygenase-1 and AKI after cardiac surgery. J Am Soc Nephrol 27:3291\u20133297","journal-title":"J Am Soc Nephrol"},{"key":"4005_CR115","doi-asserted-by":"publisher","first-page":"F662","DOI":"10.1152\/ajprenal.00421.2009","volume":"298","author":"HJ Kim","year":"2010","unstructured":"Kim HJ, Vaziri ND (2010) Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure. Am J Physiol Ren Physiol 298:F662\u2013F671","journal-title":"Am J Physiol Ren Physiol"},{"key":"4005_CR116","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1556\/2060.103.2016.4.001","volume":"103","author":"R Abo El Gheit","year":"2016","unstructured":"Abo El Gheit R, Emam MN (2016) Targeting heme oxygenase-1 in early diabetic nephropathy in streptozotocin-induced diabetic rats. Physiol Int 103:413\u2013427","journal-title":"Physiol Int"},{"key":"4005_CR117","first-page":"354","volume":"107","author":"M Mydlik","year":"2006","unstructured":"Mydlik M, Derzsiova K, Racz O, Sipulova A, Lovasova E (2006) Antioxidant therapy by oral vitamin E and vitamin E-coated dialyzer in CAPD and haemodialysis patients 48. Prague Med Rep 107:354\u2013364","journal-title":"Prague Med Rep"},{"key":"4005_CR118","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s12011-009-8504-9","volume":"135","author":"JC Lobo","year":"2010","unstructured":"Lobo JC, Torres JP, Fouque D, Mafra D (2010) Zinc deficiency in chronic kidney disease: is there a relationship with adipose tissue and atherosclerosis? Biol Trace Elem Res 135:16\u201321","journal-title":"Biol Trace Elem Res"},{"key":"4005_CR119","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1053\/jren.2002.29597","volume":"12","author":"D Mafra","year":"2002","unstructured":"Mafra D, Cuppari L, Cozzolino SM (2002) Iron and zinc status of patients with chronic renal failure who are not on dialysis. J Ren Nutr 12:38\u201341","journal-title":"J Ren Nutr"},{"key":"4005_CR120","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s00467-006-0119-1","volume":"21","author":"ST Esfahani","year":"2006","unstructured":"Esfahani ST, Hamidian MR, Madani A, Ataei N, Mohseni P, Roudbari M, Haddadi M (2006) Serum zinc and copper levels in children with chronic renal failure. Pediatr Nephrol 21:1153\u20131156","journal-title":"Pediatr Nephrol"},{"key":"4005_CR121","first-page":"116","volume":"46","author":"D Zwolinska","year":"1993","unstructured":"Zwolinska D, Morawska Z, Dobracka A, Miler M, Makulska I, Krol Z (1993) Concentration of selected trace elements in serum and erythrocytes of children with chronic renal failure and am attempt at deficiency correction with animal blood preparation. Wiad Lek 46:116\u2013119","journal-title":"Wiad Lek"},{"key":"4005_CR122","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1159\/000112413","volume":"28","author":"I Karamouzis","year":"2008","unstructured":"Karamouzis I, Sarafidis PA, Karamouzis M, Iliadis S, Haidich AB, Sioulis A, Triantos A, Vavatsi-Christaki N, Grekas DM (2008) Increase in oxidative stress but not in antioxidant capacity with advancing stages of chronic kidney disease. Am J Nephrol 28:397\u2013404","journal-title":"Am J Nephrol"},{"key":"4005_CR123","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1046\/j.1523-1755.1999.00565.x","volume":"56","author":"T Nguyen-Khoa","year":"1999","unstructured":"Nguyen-Khoa T, Massy ZA, Witko-Sarsat V, Thevenin M, Touam M, Lambrey G, Lacour B, Drueke TB, Descamps-Latscha B (1999) Critical evaluation of plasma and LDL oxidant-trapping potential in hemodialysis patients. Kidney Int 56:747\u2013753","journal-title":"Kidney Int"},{"key":"4005_CR124","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1007\/s00380-015-0785-7","volume":"31","author":"E Sato","year":"2016","unstructured":"Sato E, Tanaka A, Oyama J-I, Yamasaki A, Shimomura M, Hiwatashi A, Ueda Y, Amaha M, Nomura M, Matsumura D, Nakamura T, Node K (2016) Long-term effects of AST-120 on the progression and prognosis of pre-dialysis chronic kidney disease: a 5-year retrospective study. Heart Vessel 31:1625\u20131632","journal-title":"Heart Vessel"},{"key":"4005_CR125","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.metabol.2010.01.023","volume":"60","author":"T Nakamura","year":"2011","unstructured":"Nakamura T, Sato E, Fujiwara N, Kawagoe Y, Suzuki T, Ueda Y, Yamagishi S (2011) Oral adsorbent AST-120 ameliorates tubular injury in chronic renal failure patients by reducing proteinuria and oxidative stress generation 1. Metabolism 60:260\u2013264","journal-title":"Metabolism"},{"key":"4005_CR126","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.amjhyper.2004.11.045","volume":"18","author":"R Hisaki","year":"2005","unstructured":"Hisaki R, Fujita H, Saito F, Kushiro T (2005) Tempol attenuates the development of hypertensive renal injury in Dahl salt-sensitive rats. Am J Hypertens 18:707\u2013713","journal-title":"Am J Hypertens"},{"key":"4005_CR127","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1097\/01.ASN.0000108523.02100.E0","volume":"15","author":"A Nishiyama","year":"2004","unstructured":"Nishiyama A, Yoshizumi M, Hitomi H, Kagami S, Kondo S, Miyatake A, Fukunaga M, Tamaki T, Kiyomoto H, Kohno M, Shokoji T, Kimura S, Abe Y (2004) The SOD mimetic tempol ameliorates glomerular injury and reduces mitogen-activated protein kinase activity in Dahl salt-sensitive rats. J Am Soc Nephrol 15:306\u2013315","journal-title":"J Am Soc Nephrol"},{"key":"4005_CR128","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jnutbio.2008.12.010","volume":"21","author":"Y Tang","year":"2010","unstructured":"Tang Y, Yang Q, Lu J, Zhang X, Suen D, Tan Y, Jin L, Xiao J, Xie R, Rane M, Li X, Cai L (2010) Zinc supplementation partially prevents renal pathological changes in diabetic rats. J Nutr Biochem 21:237\u2013246","journal-title":"J Nutr Biochem"},{"key":"4005_CR129","doi-asserted-by":"publisher","first-page":"523","DOI":"10.2337\/dc06-1682","volume":"30","author":"M Soinio","year":"2007","unstructured":"Soinio M, Marniemi J, Laakso M, Pyorala K, Lehto S, Ronnemaa T (2007) Serum zinc level and coronary heart disease events in patients with type 2 diabetes. Diabetes Care 30:523\u2013528","journal-title":"Diabetes Care"},{"key":"4005_CR130","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1159\/000346948","volume":"37","author":"D Zeeuw de","year":"2013","unstructured":"de Zeeuw D, Akizawa T, Agarwal R, Audhya P, Bakris GL, Chin M, Krauth M, Lambers Heerspink HJ, Meyer CJ, McMurray JJ, Parving HH, Pergola PE, Remuzzi G, Toto RD, Vaziri ND, Wanner C, Warnock DG, Wittes J, Chertow GM (2013) Rationale and trial design of bardoxolone methyl evaluation in patients with chronic kidney disease and type 2 diabetes: the occurrence of renal events (BEACON). Am J Nephrol 37:212\u2013222","journal-title":"Am J Nephrol"},{"key":"4005_CR131","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1056\/NEJMoa1105351","volume":"365","author":"PE Pergola","year":"2011","unstructured":"Pergola PE, Raskin P, Toto RD, Meyer CJ, Huff JW, Grossman EB, Krauth M, Ruiz S, Audhya P, Christ-Schmidt H, Wittes J, Warnock DG (2011) Bardoxolone methyl and kidney function in CKD with type 2 diabetes. N Engl J Med 365:327\u2013336","journal-title":"N Engl J Med"},{"key":"4005_CR132","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1056\/NEJMoa1306033","volume":"369","author":"D Zeeuw de","year":"2013","unstructured":"de Zeeuw D, Akizawa T, Audhya P, Bakris GL, Chin M, Christ-Schmidt H, Goldsberry A, Houser M, Krauth M, Lambers Heerspink HJ, McMurray JJ, Meyer CJ, Parving HH, Remuzzi G, Toto RD, Vaziri ND, Wanner C, Wittes J, Wrolstad D, Chertow GM (2013) Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease. N Engl J Med 369:2492\u20132503","journal-title":"N Engl J Med"},{"key":"4005_CR133","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1159\/000362906","volume":"39","author":"MP Chin","year":"2014","unstructured":"Chin MP, Reisman SA, Bakris GL, O\u2019Grady M, Linde PG, McCullough PA, Packham D, Vaziri ND, Ward KW, Warnock DG, Meyer CJ (2014) Mechanisms contributing to adverse cardiovascular events in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methyl. Am J Nephrol 39:499\u2013508","journal-title":"Am J Nephrol"},{"key":"4005_CR134","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/dom.12356","volume":"17","author":"S Laecke Van","year":"2015","unstructured":"Van Laecke S, Van Biesen W, Vanholder R (2015) The paradox of bardoxolone methyl: a call for every witness on the stand? Diabetes Obes Metab 17:9\u201314","journal-title":"Diabetes Obes Metab"},{"key":"4005_CR135","doi-asserted-by":"publisher","first-page":"CD008176","DOI":"10.1002\/14651858.CD008176.pub2","volume":"10","author":"M Jun","year":"2012","unstructured":"Jun M, Venkataraman V, Razavian M, Cooper B, Zoungas S, Ninomiya T, Webster AC, Perkovic V (2012) Antioxidants for chronic kidney disease. Cochrane Database Syst Rev 10:CD008176. https:\/\/doi.org\/10.1002\/14651858.CD008176.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"4005_CR136","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1159\/000430183","volume":"36","author":"W Ding","year":"2015","unstructured":"Ding W, Wang B, Zhang M, Gu Y (2015) Tempol, a superoxide dismutase-mimetic drug, ameliorates progression of renal disease in CKD mice. Cell Physiol Biochem 36:2170\u20132182","journal-title":"Cell Physiol Biochem"},{"key":"4005_CR137","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1093\/ndt\/gfh813","volume":"20","author":"R Vanholder","year":"2005","unstructured":"Vanholder R, Massy Z, Argiles A, Spasovski G, Verbeke F, Lameire N (2005) Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant 20:1048\u20131056","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 1","key":"4005_CR138","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1755-6686.2010.00171.x","volume":"36","author":"RN Foley","year":"2010","unstructured":"Foley RN (2010) Clinical epidemiology of cardiovascular disease in chronic kidney disease. J Ren Care 36(Suppl 1):4\u20138","journal-title":"J Ren Care"},{"key":"4005_CR139","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1093\/ndt\/gfx190","volume":"33","author":"JW Groothoff","year":"2017","unstructured":"Groothoff JW, Offringa M, Grootenhuis M, Jager KJ (2017) Long-term consequences of renal insufficiency in children: lessons learned from the Dutch LERIC study. Nephrol Dial Transplant 33:552\u2013560","journal-title":"Nephrol Dial Transplant"},{"key":"4005_CR140","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1056\/NEJMoa031643","volume":"350","author":"SP Mcdonald","year":"2004","unstructured":"Mcdonald SP, Craig JC (2004) Long-term survival of children with end-stage renal disease. N Engl J Med 350:2654\u20132662","journal-title":"N Engl J Med"},{"key":"4005_CR141","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1046\/j.1523-1755.2002.00600.x","volume":"62","author":"J Himmelfarb","year":"2002","unstructured":"Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM (2002) The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 62:1524\u20131538","journal-title":"Kidney Int"},{"key":"4005_CR142","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/j.1365-2362.2005.01457.x","volume":"35","author":"D Fliser","year":"2005","unstructured":"Fliser D (2005) Asymmetric dimethylarginine (ADMA): the silent transition from an \u201curaemic toxin\u201d to a global cardiovascular risk molecule. Eur J Clin Investig 35:71\u201379","journal-title":"Eur J Clin Investig"},{"key":"4005_CR143","doi-asserted-by":"crossref","unstructured":"Togliatto G, Lombardo G, Brizzi MF (2017) The future challenge of reactive oxygen species (ROS) in hypertension: from bench to bed side. Int J Mol Sci 18","DOI":"10.3390\/ijms18091988"},{"key":"4005_CR144","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1111\/j.1538-7836.2007.02787.x","volume":"5","author":"F Ali","year":"2007","unstructured":"Ali F, Hamdulay SS, Kinderlerer AR, Boyle JJ, Lidington EA, Yamaguchi T, Soares MP, Haskard DO, Randi AM, Mason JC (2007) Statin-mediated cytoprotection of human vascular endothelial cells: a role for Kruppel-like factor 2-dependent induction of heme oxygenase-1. J Thromb Haemost 5:2537\u20132546","journal-title":"J Thromb Haemost"},{"key":"4005_CR145","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1185\/030079904X4185","volume":"20","author":"ME Bertrand","year":"2004","unstructured":"Bertrand ME (2004) Provision of cardiovascular protection by ACE inhibitors: a review of recent trials. Curr Med Res Opin 20:1559\u20131569","journal-title":"Curr Med Res Opin"},{"key":"4005_CR146","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1159\/000135655","volume":"31","author":"HO El-Mesallamy","year":"2008","unstructured":"El-Mesallamy HO, Abdel Hamid SG, Gad MZ (2008) Oxidative stress and asymmetric dimethylarginine are associated with cardiovascular complications in hemodialysis patients: improvements by L-arginine intake. Kidney Blood Press Res 31:189\u2013195","journal-title":"Kidney Blood Press Res"},{"key":"4005_CR147","doi-asserted-by":"crossref","unstructured":"Fliser D, Kielstein JT, Haller H, Bode-Boger SM (2003) Asymmetric dimethylarginine: a cardiovascular risk factor in renal disease? Kidney Int Suppl:S37\u2013S40","DOI":"10.1046\/j.1523-1755.63.s84.11.x"},{"key":"4005_CR148","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1161\/STROKEAHA.109.552539","volume":"40","author":"R Maas","year":"2009","unstructured":"Maas R, Xanthakis V, Polak JF, Schwedhelm E, Sullivan LM, Benndorf R, Schulze F, Vasan RS, Wolf PA, Boger RH, Seshadri S (2009) Association of the endogenous nitric oxide synthase inhibitor ADMA with carotid artery intimal media thickness in the Framingham Heart Study offspring cohort. Stroke 40:2715\u20132719","journal-title":"Stroke"},{"key":"4005_CR149","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.immuni.2013.02.009","volume":"38","author":"T Speer","year":"2013","unstructured":"Speer T, Rohrer L, Blyszczuk P, Shroff R, Kuschnerus K, Kr\u00e4nkel N, Kania G, Zewinger S, Akhmedov A, Shi Y, Martin T, Perisa D, Winnik S, M\u00fcller MF, Sester U, Wernicke G, Jung A, Gutteck U, Eriksson U, Geisel J, Deanfield J, von Eckardstein A, L\u00fcscher TF, Fliser D, Bahlmann FH, Landmesser U (2013) Abnormal high-density lipoprotein induces endothelial dysfunction via activation of toll-like receptor-2. Immunity 38:754\u2013768","journal-title":"Immunity"},{"key":"4005_CR150","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1681\/ASN.2013111212","volume":"25","author":"R Shroff","year":"2014","unstructured":"Shroff R, Speer T, Colin S, Charakida M, Zewinger S, Staels B, Chinetti-Gbaguidi G, Hettrich I, Rohrer L, O\u2019Neill F, McLoughlin E, Long D, Shanahan CM, Landmesser U, Fliser D, Deanfield JE (2014) HDL in children with CKD promotes endothelial dysfunction and an abnormal vascular phenotype. J Am Soc Nephrol 25:2658\u20132668","journal-title":"J Am Soc Nephrol"},{"key":"4005_CR151","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.metabol.2014.10.020","volume":"64","author":"R Kaseda","year":"2015","unstructured":"Kaseda R, Jabs K, Hunley TE, Jones D, Bian A, Allen RM, Vickers KC, Yancey PG, Linton MF, Fazio S, Kon V (2015) Dysfunctional high-density lipoproteins in children with chronic kidney disease. Metabolism 64:263\u2013273","journal-title":"Metabolism"},{"key":"4005_CR152","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s00467-007-0643-7","volume":"23","author":"C Hadtstein","year":"2008","unstructured":"Hadtstein C, Schaefer F (2008) Hypertension in children with chronic kidney disease: pathophysiology and management. Pediatr Nephrol 23:363\u2013371","journal-title":"Pediatr Nephrol"},{"key":"4005_CR153","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1007\/s00467-008-0874-2","volume":"23","author":"G Hussein","year":"2008","unstructured":"Hussein G, Bughdady Y, Kandil ME, Bazaraa HM, Taher H (2008) Doppler assessment of brachial artery flow as a measure of endothelial dysfunction in pediatric chronic renal failure. Pediatr Nephrol 23:2025\u20132030","journal-title":"Pediatr Nephrol"},{"key":"4005_CR154","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1007\/s00467-008-0815-0","volume":"23","author":"AC Wilson","year":"2008","unstructured":"Wilson AC, Urbina E, Witt SA, Glascock BJ, Kimball TR, Mitsnefes M (2008) Flow-mediated vasodilatation of the brachial artery in children with chronic kidney disease. Pediatr Nephrol 23:1297\u20131302","journal-title":"Pediatr Nephrol"},{"key":"4005_CR155","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1007\/s00467-016-3350-4","volume":"31","author":"P Khandelwal","year":"2016","unstructured":"Khandelwal P, Murugan V, Hari S, Lakshmy R, Sinha A, Hari P, Bagga A (2016) Dyslipidemia, carotid intima-media thickness and endothelial dysfunction in children with chronic kidney disease. Pediatr Nephrol 31:1313\u20131320","journal-title":"Pediatr Nephrol"},{"key":"4005_CR156","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.jpeds.2006.08.017","volume":"149","author":"MM Mitsnefes","year":"2006","unstructured":"Mitsnefes MM, Kimball TR, Kartal J, Witt SA, Glascock BJ, Khoury PR, Daniels SR (2006) Progression of left ventricular hypertrophy in children with early chronic kidney disease: 2-year follow-up study. J Pediatr 149:671\u2013675","journal-title":"J Pediatr"},{"key":"4005_CR157","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1681\/ASN.2009060609","volume":"21","author":"M Mitsnefes","year":"2010","unstructured":"Mitsnefes M, Flynn J, Cohn S, Samuels J, Blydt-Hansen T, Saland J, Kimball T, Furth S, Warady B (2010) Masked hypertension associates with left ventricular hypertrophy in children with CKD. J Am Soc Nephrol 21:137\u2013144","journal-title":"J Am Soc Nephrol"},{"key":"4005_CR158","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1681\/ASN.2012121197","volume":"25","author":"JC Kupferman","year":"2014","unstructured":"Kupferman JC, Aronson Friedman L, Cox C, Flynn J, Furth S, Warady B, Mitsnefes M (2014) BP control and left ventricular hypertrophy regression in children with CKD. J Am Soc Nephrol 25:167\u2013174","journal-title":"J Am Soc Nephrol"},{"key":"4005_CR159","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1136\/heartjnl-2012-302818","volume":"99","author":"WE Moody","year":"2013","unstructured":"Moody WE, Edwards NC, Chue CD, Ferro CJ, Townend JN (2013) Arterial disease in chronic kidney disease. Heart 99:365\u2013372","journal-title":"Heart"},{"key":"4005_CR160","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/kisup.2011.5","volume":"1","author":"G London","year":"2011","unstructured":"London G, Covic A, Goldsmith D, Wiecek A, Suleymanlar G, Ortiz A, Massy Z, Lindholm B, Martinez-Castelao A, Fliser D, Agarwal R, Jager KJ, Dekker FW, Blankestijn PJ, Zoccali C (2011) Arterial aging and arterial disease: interplay between central hemodynamics, cardiac work, and organ flow-implications for CKD and cardiovascular disease. Kidney Int Suppl 1:10\u201312","journal-title":"Kidney Int Suppl"},{"key":"4005_CR161","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.kint.2016.09.024","volume":"91","author":"M Vervloet","year":"2017","unstructured":"Vervloet M, Cozzolino M (2017) Vascular calcification in chronic kidney disease: different bricks in the wall? Kidney Int 91:808\u2013817","journal-title":"Kidney Int"},{"key":"4005_CR162","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s12265-012-9359-6","volume":"5","author":"JA Chirinos","year":"2012","unstructured":"Chirinos JA (2012) Arterial stiffness: basic concepts and measurement techniques. J Cardiovasc Transl Res 5:243\u2013255","journal-title":"J Cardiovasc Transl Res"},{"key":"4005_CR163","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1053\/j.ajkd.2009.04.027","volume":"54","author":"AC Wilson","year":"2009","unstructured":"Wilson AC, Mitsnefes MM (2009) Cardiovascular disease in CKD in children: update on risk factors, risk assessment, and management. Am J Kidney Dis 54:345\u2013360","journal-title":"Am J Kidney Dis"},{"key":"4005_CR164","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1007\/s11255-015-1009-x","volume":"47","author":"Y Ma","year":"2015","unstructured":"Ma Y, Zhou L, Dong J, Zhang X, Yan S (2015) Arterial stiffness and increased cardiovascular risk in chronic kidney disease. Int Urol Nephrol 47:1157\u20131164","journal-title":"Int Urol Nephrol"},{"key":"4005_CR165","doi-asserted-by":"publisher","first-page":"e3362","DOI":"10.1097\/MD.0000000000003362","volume":"95","author":"HY Choi","year":"2016","unstructured":"Choi HY, Park SK, Yun GY, Choi AR, Lee JE, Ha SK, Park HC (2016) Glycated albumin is independently associated with arterial stiffness in non-diabetic chronic kidney disease patients. Medicine 95:e3362","journal-title":"Medicine"},{"key":"4005_CR166","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1053\/j.jrn.2011.10.019","volume":"22","author":"Y Nishizawa","year":"2012","unstructured":"Nishizawa Y, Koyama H, Inaba M (2012) AGEs and cardiovascular diseases in patients with end-stage renal diseases. J Ren Nutr 22:128\u2013133","journal-title":"J Ren Nutr"},{"key":"4005_CR167","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.arcmed.2014.04.002","volume":"45","author":"M Rossi","year":"2014","unstructured":"Rossi M, Campbell KL, Johnson DW, Stanton T, Vesey DA, Coombes JS, Weston KS, Hawley CM, McWhinney BC, Ungerer JPJ, Isbel N (2014) Protein-bound uremic toxins, inflammation and oxidative stress: a cross-sectional study in stage 3-4 chronic kidney disease. Arch Med Res 45:309\u2013317","journal-title":"Arch Med Res"},{"key":"4005_CR168","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.lfs.2017.07.027","volume":"185","author":"H Gao","year":"2017","unstructured":"Gao H, Liu S (2017) Role of uremic toxin indoxyl sulfate in the progression of cardiovascular disease. Life Sci 185:23\u201329","journal-title":"Life Sci"},{"key":"4005_CR169","doi-asserted-by":"publisher","first-page":"340","DOI":"10.4103\/0971-4065.103907","volume":"22","author":"SK Annavarajula","year":"2012","unstructured":"Annavarajula SK, Dakshinamurty KV, Naidu MU, Reddy CP (2012) The effect of L-arginine on arterial stiffness and oxidative stress in chronic kidney disease. Indian J Nephrol 22:340\u2013346","journal-title":"Indian J Nephrol"},{"key":"4005_CR170","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.2174\/1381612823666170417130115","volume":"23","author":"M Schuchardt","year":"2017","unstructured":"Schuchardt M, Herrmann J, Tolle M, van der Giet M (2017) Xanthine oxidase and its role as target in cardiovascular disease: cardiovascular protection by enzyme inhibition? Curr Pharm Des 23:3391\u20133404","journal-title":"Curr Pharm Des"},{"key":"4005_CR171","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1161\/HYPERTENSIONAHA.115.06344","volume":"67","author":"RL MacIsaac","year":"2016","unstructured":"MacIsaac RL, Salatzki J, Higgins P, Walters MR, Padmanabhan S, Dominiczak AF, Touyz RM, Dawson J (2016) Allopurinol and cardiovascular outcomes in adults with hypertension. Hypertension 67:535\u2013540","journal-title":"Hypertension"},{"key":"4005_CR172","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.2174\/0929867053764635","volume":"12","author":"M Valko","year":"2005","unstructured":"Valko M, Morris H, Cronin MTD (2005) Metals, toxicity and oxidative stress. Curr Top Med Chem 12:1161\u20131208","journal-title":"Curr Top Med Chem"},{"key":"4005_CR173","unstructured":"Atkinson MA, Warady BA (2017) Anemia in chronic kidney disease. Pediatr Nephrol:1\u201312"},{"key":"4005_CR174","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1093\/ndt\/gft033","volume":"28","author":"F Locatelli","year":"2013","unstructured":"Locatelli F, Barany P, Covic A, De FA, Del VL, Goldsmith D, Horl W, London G, Vanholder R, Van BW (2013) Kidney disease: improving global outcomes guidelines on anaemia management in chronic kidney disease: a European renal best practice position statement. Nephrol Dial Transplant 28:1346\u20131359","journal-title":"Nephrol Dial Transplant"},{"key":"4005_CR175","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1007\/s00467-011-1946-2","volume":"26","author":"R Baracco","year":"2011","unstructured":"Baracco R, Saadeh S, Valentini R, Kapur G, Jain A, Mattoo TK (2011) Iron deficiency in children with early chronic kidney disease. Pediatr Nephrol 26:2077\u20132080","journal-title":"Pediatr Nephrol"},{"key":"4005_CR176","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00467-006-0381-2","volume":"23","author":"SM Koshy","year":"2008","unstructured":"Koshy SM, Geary DF (2008) Anemia in children with chronic kidney disease. Pediatr Nephrol 23:209\u2013219","journal-title":"Pediatr Nephrol"},{"key":"4005_CR177","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1093\/ndt\/gfp066","volume":"24","author":"I Dursun","year":"2009","unstructured":"Dursun I, Poyrazoglu HM, Gunduz Z, Ulger H, Y\u00fdk\u00fdlmaz A, Dusunsel R, Pat\u00fdroglu T, Gurgoze M (2009) The relationship between circulating endothelial microparticles and arterial stiffness and atherosclerosis in children with chronic kidney disease. Nephrol Dial Transplant 24:2511\u20132518","journal-title":"Nephrol Dial Transplant"},{"key":"4005_CR178","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1093\/ajcn\/84.1.252","volume":"84","author":"P Castilla","year":"2006","unstructured":"Castilla P, Echarri R, Davalos A, Cerrato F, Ortega H, Teruel JL, Lucas MF, Gomez-Coronado D, Ortuno J, Lasuncion MA (2006) Concentrated red grape juice exerts antioxidant, hypolipidemic, and antiinflammatory effects in both hemodialysis patients and healthy subjects. Am J Clin Nutr 84:252\u2013262","journal-title":"Am J Clin Nutr"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-018-4005-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-018-4005-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-018-4005-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T01:13:41Z","timestamp":1720487621000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-018-4005-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,13]]},"references-count":178,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["4005"],"URL":"https:\/\/doi.org\/10.1007\/s00467-018-4005-4","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,13]]},"assertion":[{"value":"21 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}